Home » Newsletters » BioWorld Science

BioWorld Science

June 16, 2021

View Archived Issues

FDA clears IND application for phase II study of LPCN-1154 in postpartum depression

LEO Pharma initiates phase IIa study of LEO-152020 in cholinergic urticaria

LLT1 is a poor prognostic factor in HPV-negative oropharyngeal SCC

Veraxa partners with Quadira on ADCs for oncology indications

Avidea advances lead SNAPvax TV candidate for MS toward clinic

CAMP4 raises funds to expand its platform and advance multiple RNA therapies

Otonomy announces phase I/II study expansion for OTO-413 in speech-in-noise hearing difficulty

Chinese researchers patent NMDA receptor antagonists

Medshine Discovery discloses ROS1 inhibitors

Shenzhen Salubris Pharmaceuticals synthesizes FXIa inhibitors

FDA authorizes phase Ib/II study of Anktiva plus chemoimmunotherapy in TNBC

Nankai University identifies new compounds for skin injury

CRISPR and Capsida enter strategic collaboration to develop gene-edited therapies

Lentigen Technology presents new CAR cells for cancer immunotherapy

Investigator-initiated study of Salarius' seclidemstat in hematologic cancers begins

Differences in tumor uptake between [18F]FP-R01-MG-F2 and FDG in pancreatic cancer

Tylenol could find role in gene therapy

Positive safety data reported from cohort 1 of OASIS study evaluating CLS-AX in wet AMD

FDA clears IND application for anti-CCR8 antibody JTX-1811

FDA approves IND for phase IIb PORTICO study of vafidemstat in borderline personality disorder

Linnaeus and Merck & Co. expand collaborative evaluation of LNS-8801 with Keytruda

First-in-human data for FLT3 inhibitor FF-10101

ORIN-1001 shows promising preliminary antitumor activity in heavily pretreated solid tumors

Ashvattha reports phase II interim data on OP-101 to treat hyperinflammation in severe COVID-19

Harbour BioMed and Dana-Farber Cancer Institute to codevelop novel biotherapies for cancer

Servier and Oncodesign's collaboration in Parkinson's selects preclinical candidate

Spero initiates new phase I trials of SPR-206 for MDR Gram-negative infections

Mnemo Therapeutics to accelerate development of EnfiniT platform

SOX2 predicts laryngeal cancer risk in patients with premalignant lesions

Daiichi Sankyo discontinues development of nafamostat inhalation formulation for COVID-19 in Japan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...